EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bacterial co-infections in cancer patients with COVID-19: predictors and antimicrobial resistance trends

Rasha M Abdel-Hamid, Ahmed Bayoumi, Mona S Abdellateif, Hend A Nooh, Lobna Refaat, Eman Z Kandeel, Safaa S Hassan

The Journal of Infection in Developing Countries · 2024

DOI: 10.3855/jidc.19731 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infection in Developing Countries, 2024. Verfasst von Rasha M Abdel-Hamid und 6 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pathology Department, National Cancer Institute, Cairo University, Cairo, Egypt. Hauptthemen laut MEDLINE: COVID-19, Coinfection, Neoplasms, Bacterial Infections. Die Arbeit wurde bisher 7-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Within the context of the coronavirus disease 2019 (COVID-19) pandemic, this study investigated the multifaceted challenges of bacterial infections in cancer patients with COVID-19. It focuses on clinical predictors, resistance patterns, and microbiological characteristics. Methodology: Over 18 months, 112 adult cancer patients with coronavirus infection confirmed by reverse transcription polymerase chain reaction (RT-PCR) were enrolled. Bloodstream and respiratory samples were evaluated for bacterial infection using the Phoenix automation system for definitive species identification. In vitro susceptibility testing followed the Clinical Laboratory Standards Institute (CLSI) M100-Ed30 guidelines.

Results

Bacterial infections affected 25.0% of patients, encompassing bacteremia (21.4%) and respiratory tract infections (8.0%). Multivariable analysis identified hypertension, age < 60, and critical COVID-19 as significant predictors for bacterial infections (p-values = 0.024, 0.029, and 0.039, respectively). Most patients received antimicrobial therapy (93.8%), including last-resort carbapenems (52.7%) and colistin (8.9%). Thirty-three bacterial isolates were identified, with secondary infections doubling co-infection rates. Escherichia coli, Klebsiella species, and Staphylococcus aureus were the most common co-infecting species, while Klebsiella, Acinetobacter, and Pseudomonas species were more frequently associated with secondary infections. Alarmingly, 84.8% of isolates displayed high resistance patterns. All isolated S. aureus species were methicillin-resistant, and 62.5% of Gram-negative bacteria were exclusively sensitive to colistin.

Conclusions

The dominance of highly transmissible hospital-acquired bacterial species, with increased resistance and extensive antibiotic use in COVID-19 patients, necessitates strict infection control and antimicrobial stewardship. Developing customized antimicrobial strategies for cancer patients with COVID-19 is crucial to managing bacterial infections effectively and improving patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19CoinfectionNeoplasmsBacterial InfectionsAnti-Bacterial AgentsHumansMaleMiddle AgedFemaleAgedAdultSARS-CoV-2Drug Resistance, BacterialMicrobial Sensitivity TestsBacteremiaAged, 80 and overRespiratory Tract InfectionsBacteria

Stichwörter der Autor:innen

COVID-19Criticalcancer patientsco-infectionsmultidrug-resistantsecondary infectionssevere

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Clinical Pathology Department, National Cancer Institute, Cairo University, Cairo, Egypt.
  • Pediatric Oncology Department, National Cancer Institute, Cairo University, Cairo, Egypt.
  • Medical Biochemistry and Molecular Biology, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, Egypt.

Zitieren

APA

Abdel-Hamid, R. M., Bayoumi, A., Abdellateif, M. S., Nooh, H. A., Refaat, L., Kandeel, E. Z., & Hassan, S. S. (2024). Bacterial co-infections in cancer patients with COVID-19: predictors and antimicrobial resistance trends. The Journal of Infection in Developing Countries. https://doi.org/10.3855/jidc.19731

Vancouver

Abdel-Hamid RM, Bayoumi A, Abdellateif MS, Nooh HA, Refaat L, Kandeel EZ, et al. Bacterial co-infections in cancer patients with COVID-19: predictors and antimicrobial resistance trends. The Journal of Infection in Developing Countries. 2024. doi:10.3855/jidc.19731

BibTeX
@article{AbdelHamid2024,
  author = {Abdel-Hamid, Rasha M and Bayoumi, Ahmed and Abdellateif, Mona S and Nooh, Hend A and Refaat, Lobna and Kandeel, Eman Z and Hassan, Safaa S},
  title = {Bacterial co-infections in cancer patients with COVID-19: predictors and antimicrobial resistance trends},
  journal = {The Journal of Infection in Developing Countries},
  year = {2024},
  doi = {10.3855/jidc.19731}
}
Kostenlos starten →